openPR Logo
Press release

Infectious Disease Therapeutics Global Market Report 2024 - By Growth, Size, Share And Analysis, Forecast To 2033

07-02-2024 07:29 AM CET | Health & Medicine

Press release from: The Business research company

Infectious Disease Therapeutics Market

Infectious Disease Therapeutics Market

"The new report published by The Business Research Company, titled Infectious Disease Therapeutics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the infectious disease therapeutics market size has grown strongly in recent years. It will grow from $132.14 billion in 2023 to $141.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The infectious disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $184.17 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15594&type=smp

Infectious Diseases On The Upswing A Global Health Concern
The rising prevalence of infectious diseases is expected to propel the growth of the infectious disease therapeutics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions. The rising infectious diseases are due to several key factors such as climate change and environmental disruption, antimicrobial resistance, weakened immune systems, increased interactions with animals, and ecological disturbances. Infectious disease therapeutics play a vital role in treating infections, reducing morbidity and mortality, and controlling the spread of communicable diseases within communities and across populations. For instance, according to the gov. uk, a UK-based public sector information website, in England, there were 3,805 new HIV diagnoses in 2022, marking a 22% increase from the 3,118 cases reported in 2021 and a 26% rise from the 3,026 cases reported in 2020. Therefore, the rising prevalence of infectious diseases drives the infectious disease therapeutics market.

Corporate Initiatives In Infectious Disease Therapeutics Advancing Treatment, Resisting Resistance, and Promoting Global Health Equity
Major companies operating in the infectious disease therapeutics market are investing in infectious disease drugs to develop more effective treatments, combat antimicrobial resistance, expand their product portfolios, and address emerging infectious threats. These investments aim to improve patient outcomes, meet unmet medical needs, and contribute to global public health efforts to control and manage infectious diseases. For instance, in June 2022, GSK, a UK-based healthcare company invested £1 billion(USD 1.09 billion) to proactively address infectious diseases in lower-income countries. This initiative aims to enhance research and development efforts to combat diseases that disproportionately affect these regions. The disparity in health research funding and resources between high-income and low- and middle-income countries underscores the urgency for such proactive investments to improve population health equitably. 

The infectious disease therapeutics market covered in this report is segmented -
1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15594&type=discount

Major companies operating in the infectious disease therapeutics market are Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.

Contents of the report:
1. Executive Summary
2. Infectious Disease Therapeutics Market Report Structure
3. Infectious Disease Therapeutics Market Trends And Strategies
4. Infectious Disease Therapeutics Market - Macro Economic Scenario
5. Infectious Disease Therapeutics Market Size And Growth
…..
27. Infectious Disease Therapeutics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/infectious-disease-therapeutics-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infectious Disease Therapeutics Global Market Report 2024 - By Growth, Size, Share And Analysis, Forecast To 2033 here

News-ID: 3560984 • Views:

More Releases from The Business research company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Infectious

Infectious Disease Therapeutics Market - Infectious Disease Solutions: Revolutio …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Infectious Disease Therapeutics Market. Infectious Disease Therapeutics Market: https://www.growthplusreports.com/report/infectious-disease-therapeutics-market/9210 The Infectious Disease Therapeutics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Infectious Disease Diagnostics Market Owing to the Increasing Prevalence of Infe …
According to Precision Business Insights (PBI) latest report, the infectious disease diagnostics market is expected to be worth USD 34,599.0 million in 2022, growing at a 6.4% CAGR from 2022 to 2028. Global Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments and Software & Services), By Type of Testing (Laboratory Testing and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays
Increasing Prevalence of Infectious Diseases to Augment the Point-of-Care (POC) …
Point-of-care (POC) diagnosis includes sample testing to facilitate rapid diagnosis and decide on treatment planning accordingly. Infectious diseases often need to be diagnosed early, as they can be fatal against the immune system. POC infectious disease diagnostics allows early detection of diseases and can impact the medical outcome of treatment of the disease. Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/63 The U.S. FDA (United States Food and Drug Administration) is
Infectious Disease Diagnostics Market Entry Strategies, Countermeasures, Economi …
Market Expertz has published its latest research study titled 'Global Infectious Disease Diagnostics Market Report Forecast to 2027' gives a detailed assessment of the industry to offer vital information by evaluating the prevalent trends observed in the sector. The report includes valuable market insights provided by the industry experts by way of surveys and interviews as part of primary research. The authors of the study also undertake secondary research, which
Infectious Disease Diagnostics Market
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased